FIELD: manufacturing technology.
SUBSTANCE: invention relates to a method of producing an oxidized dextran, suitable for its visualization in blood serum, involving reaction of oxidized dextran with a label for imaging thereof at temperature of 80–90 °C, as a mark for imaging is used acridonacetic acid hydrazide; reaction of acridonacetic acid hydrazine – oxidized dextran is carried out at a ratio of components of 1:10 respectively in terms of weight of dry substance for 90 minutes, filtering the obtained suspension, cooling it to room temperature, adding a liposome-forming agent, holding the obtained liposomal form of the oxidized dextran derivative at temperature of 4–6 °C for at least 24 hours, then filtering it using a microfilter.
EFFECT: obtaining an oxidized dextran derivative which enables to determine content of its liposomal forms in blood serum.
3 cl, 2 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREPARING BIOTINYLATED DERIVATIVE OF OXIDISED DEXTRAN | 2013 |
|
RU2537246C1 |
PHARMACEUTICAL TUBERCULOSIS COMPOSITION | 2008 |
|
RU2372914C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING FUNGOID DISEASES | 2010 |
|
RU2430730C1 |
DRUG STIMULATING PRODUCTION OF GRANULOCYTE-MACROPHAGE COLONY-FORMING FACTOR IN CELLS OF MONONUCLEAR PHAGOCYTE SYSTEM | 2010 |
|
RU2438676C1 |
METHOD OF OBTAINING MAGNETOSENSITIVE LIPOSOMES | 2007 |
|
RU2357724C1 |
METHOD FOR CELLULAR LABORATORY IMMUNITY OF LABORATORY ANIMALS | 2018 |
|
RU2709809C1 |
AGENT WITH ISONIAZID-CONTAINING LIPOSOMES | 2016 |
|
RU2622755C1 |
METHOD FOR PRODUCING FLUORESCENT DERIVATIVES OF ARABINOGALACTAN | 2021 |
|
RU2768707C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING CYTOSTATIC MYELOSUPPRESSION | 2012 |
|
RU2471490C1 |
METHOD FOR PREVENTION OF GASTROINTESTINAL DISEASES OF YOUNG CATTLE | 2019 |
|
RU2722161C1 |
Authors
Dates
2019-06-03—Published
2019-02-12—Filed